The Quantellect read.As of Nov 19, 2026, 5 active firms cover PACS Group, Inc: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $57.00 to $62.00, so the covering firms are broadly aligned. The average target of $58.80 sits 27% above the current $46.28. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.69 next quarter toward $2.85 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$58.80
+27.1% upside
Average target across 5 active firms as of Nov 19, 2026 vs $46.28 current
Highest Target$62.00
Average Target$58.80
Lowest Target$57.00
Detailed analyst forecasts for PACS
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate PACS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PACS EPS & revenue forecast
EPS · NEXT QUARTER
$0.69
Range $0.66 – $0.70 · 3 analysts · +8% YoY
Next period, 3 analysts expect PACS Group, Inc. to earn $0.69 a share (range $0.66 – $0.70), versus $0.64 a year earlier. Full-year consensus is $2.61, growing to $2.85 the year after.
REVENUE · NEXT QUARTER
$1.8B
Range $1.7B – $1.8B · 3 analysts · +24% YoY
Revenue is expected to reach $1.8B (range $1.7B – $1.8B), +23.5% year-over-year. Full-year consensus is $6.0B, rising to $7.0B next year.
Top analysts covering PACS Group, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PACS.
#1
DM
David Macdonald
Truist Securities · Rank #111
Buy
No targeton PACS
Overall win rate
50%
+ Follow
#2
Tao Qiu
Macquarie · Rank #126
Buy
$24.00-48.1% to target
Overall win rate
45%
+ Follow
#3
Ben Hendrix
RBC Capital · Rank #150
Buy
$57.00+23.2% to target
Overall win rate
44%
+ Follow
#4
AR
A.J. Rice
UBS · Rank #365
Buy
$60.00+29.6% to target
Overall win rate
35%
+ Follow
#5
BR
Benjamin Rossi
JP Morgan
Buy
$58.00+25.3% to target
Coverage
—
+ Follow
PACS stock forecast FAQ
What is PACS's average 12-month price target?+
The 5 active firms with a live target average $58.80 for PACS Group, Inc. over the next 12 months, ranging from a $62.00 high to a $57.00 low, as of Nov 19, 2026.
Is PACS stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for PACS?+
The Street-high target is $62.00 (Truist Securities), and the Street-low is $57.00 (Oppenheimer). The average of all 5 active-firm targets is $58.80.
How many active Wall Street firms cover PACS?+
5 active firms have a recognized rating on PACS Group, Inc. as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PACS?+
Among analysts who currently cover PACS, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #111). Their current call is Buy.
What is PACS Group, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.69 per share (range $0.66 – $0.70) across 3 analysts. Full-year EPS is projected at $2.61, rising to $2.85 the following year.
How much revenue is PACS Group, Inc. expected to report next quarter?+
Consensus revenue is $1.8B (range $1.7B – $1.8B). Full-year revenue is projected at $6.0B, growing to $7.0B next year.
Have analysts been upgrading or downgrading PACS lately?+
As of Nov 19, 2026, 5 of 5 active firms rate PACS a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PACS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.